Vendor, Costa Mesa, CA
Integrated Behavioral Health, Inc.
UEI L9YZF5SG6WN1, CAGE 52J98
7 awards and $2,344,536 obligated between February 28, 2024 and August 18, 2026, 86% under full and open competition, against 1.3 offers on average where reported. 4 of the awards trace back to a SAM.gov solicitation on this site.
Sells to
Awarding agencies by dollars.
| Food and Drug Administration | $1,344,536 |
| Centers for Disease Control and Prevention | $1,000,000 |
Industries
NAICS on the awards, by dollars.
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 6 |
| Not Competed | 1 |
| Delivery Order | 4 |
| Purchase Order | 1 |
Hear when Integrated Behavioral Health, Inc. wins an award and when a contract it holds is about to end.Follow it
Contracts ending soon
Contracts Integrated Behavioral Health, Inc. holds whose performance ends in the next 19 months, by published end date. Each one is a recompete to prepare for.
- Ending
- 4
- Obligated so far
- $1,344,536
- Soonest
- December 29, 2026
The 4 contracts, the office behind each one and the dates are in the workspace. See them
Competes with
Vendors selling research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology) to Food and Drug Administration, by dollars.
| University of ConnecticutStorrs, CT | $11,942,361 |
| The Medical Device Innovation ConsortiumArlington, VA | $6,661,062 |
| Rochester Institute of TechnologyRochester, NY | $4,223,295 |
| University of Massachusetts LowellLowell, MA | $3,769,119 |
| Beth Israel Deaconess Medical Center, Inc.Boston, MA | $2,492,797 |
| National Institute for Pharmaceutical Technology & Education Inc.Minneapolis, MN | $2,151,882 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75D30123P17566Purchase Order, July 5, 2024, Not Competed, 1 offers | CDC Office of Acquisition ServicesCenters for Disease Control and Prevention | NavipproNAICS 541990, PSC R499 | $1,000,000 |
| 75F40122F19002Delivery Order, March 25, 2024, Full and Open Competition, 1 offers | FDA Office of Acq Grant SVCSFood and Drug Administration | Understanding the Prevalence, Experiences, Knowledge, and Perceptions of Falsified and Unapproved Pharmaceuticals in an Enriched Population NAICS 541715, PSC B529 | $561,035 |
| 75F40121F19001Delivery Order, February 28, 2024, Full and Open Competition, 1 offers | FDA Office of Acq Grant SVCSFood and Drug Administration | Data Resource for Post-Marketing Surveillance of Nonmedical Use (Nmu) of Pharmaceuticals and Use of Illicit Drug Substances - Six Month SurvNAICS 541715, PSC B529 | $428,079 |
| 75F40126F19003Delivery Order, August 17, 2026, Full and Open Competition, 1 offers | FDA Office of Acq Grant SVCSFood and Drug Administration | Eo 14398 - Post-Marketing RX Drug Abuse Surveillance DataNAICS 541715, PSC B529 | $309,073 |
| 75F40126F19004Delivery Order, August 18, 2026, Full and Open Competition, 1 offers | FDA Office of Acq Grant SVCSFood and Drug Administration | Redefining Nonmedical Use of Buprenorphine and Methadone in the Addiction Severity Index-Multimedia Version (Asi-Mv) Clinical Assessment TooNAICS 541715, PSC B529 | $46,349 |
| 75F40121D00032April 5, 2024, Full and Open Competition, 2 offers | FDA Office of Acq Grant SVCSFood and Drug Administration | Data Resources for Post-Marketing Surveillance of Nonmedical Use of Pharmaceuticals and Use of Illicit Drug SubstancesNAICS 541715, PSC B529 | $0 |
| 75F40126D00011May 18, 2026, Full and Open Competition, 2 offersSolicitation | FDA Office of Acq Grant SVCSFood and Drug Administration | Non-Medical Use (Nmu) Surveillance IDIQNAICS 541720, PSC AN41 | $0 |
- Places of performance
- MarylandGeorgiaCalifornia
- Product and service codes
- B529 Scientific Data StudiesR499 Other Professional ServicesAN41 Health R&D Services; Health Care - Other; Basic Research
- Transactions
- 13 across 7 awards